Virtual Hypertension Management Pilot

Hypertension Clinical Trial

Official title:

Virtual Hypertension Management Pilot: Randomized Evaluation of Electronic Health Record-connected Blood Pressure Cuffs in a Clinical Pharmacist Panel.

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT03291535
• Other study ID #: 12397
• Status: Completed
• Phase: N/A
• Start date: July 26, 2017
• Est. completion date: March 1, 2022

Study information

• Verified date: August 2022
• Source: Stanford University
• Contact: n/a
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

Investigators are examining the quality improvement impact of providing patients with a an electronic health record-connected blood pressure cuff. Investigators will give half of patients already eligible for hypertension management within a clinical pharmacist panel, the ability to upload their blood pressure data into Stanford's electronic health record.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 75
• Est. completion date: March 1, 2022
• Est. primary completion date: March 1, 2022
• Accepts healthy volunteers: No
• Gender: All
• Age group: 18 Years and older

Eligibility

Inclusion Criteria:

• Hypertension as defined by clinical pharmacist usual care panel (2 or more readings of blood pressure >140/90)

Exclusion Criteria:

• Pregnancy
• Chronic kidney disease III or IV
• Systolic heart failure with ejection fraction <35%
• Current use of 3 or more anti-hypertension drugs

Related Conditions & MeSH terms

• Digital Health
• Electronic Health Record
• Hypertension

Intervention

Other:
• Connected-device
This intervention will allow patients to upload blood pressure data automatically from a blood pressure cuff into the electronic health record.
• Usual care
This intervention will consist of usual clinical care as determined by the clinical pharmacist.

Locations

Country	Name	City	State
United States	Stanford Primary Care	Portola Valley	California
United States	Stanford Primary Care Clinic	Santa Clara	California

Sponsors (1)

Lead Sponsor	Collaborator
Stanford University

Country where clinical trial is conducted

United States, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Change in blood pressure over time in control group vs. the intervention group	Difference in the change in blood pressure between the control group and intervention group.	From enrollment to 6 months later
Secondary	Patient visits	Measurement of the number of in-person visits	From enrollment to 6 months later
Secondary	Patient remote interactions	Measurement of the number of patient phone calls plus patient-portal messages to the clinical pharmacist	From enrollment to 6 months later
Secondary	Medication changes	Number of changes in medication or medication dose	From enrollment to 6 months later
Secondary	Blood pressure control	Time to reach target blood pressure control (Adults 18-59 years of age <140/90 mm Hg, Adults 60-85 years of age, without a diagnosis of diabetes, <150/90 mm Hg, Adults 60-85 years of age, with a diagnosis of diabetes, <140/90 mm Hg)	From enrollment to 6 months later